ClinicalTrials.Veeva

Menu

Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile?

R

Rambam Health Care Campus

Status

Completed

Conditions

Migraine

Treatments

Drug: Amitriptyline
Drug: Topiramate

Study type

Interventional

Funder types

Other

Identifiers

NCT01161017
Migraine06CTIL

Details and patient eligibility

About

Mechanism-based choice of therapy for pain:

Can successful prevention of migraine be coupled to a psychophysical pain modulation profile?

Enrollment

67 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • female and male migraine patients with a number of month attacks ≥ 4,
  • age 18-75,
  • without any other chronic pain.

Exclusion criteria

  • any migraine preventive treatment for last 6 month & psychiatric,
  • language or cognitive dysfunction precluding use of psychophysics.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

67 participants in 2 patient groups

1 Amitriptyline.
Active Comparator group
Description:
Amitriptyline
Treatment:
Drug: Amitriptyline
2 Topiramate
Active Comparator group
Description:
Topiramate
Treatment:
Drug: Topiramate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems